Apoptosis, Senescence and Cancer by David A. GewirtzApoptosis, Senescence and Cancer by David A. Gewirtz

Apoptosis, Senescence and Cancer

byDavid A. GewirtzEditorShawn E. Holt, Steven Grant

Paperback | December 9, 2010

Pricing and Purchase Info


Earn 2,340 plum® points

Prices and offers may vary in store


Ships within 1-2 weeks

Ships free on orders over $25

Not available in stores


Apoptosis, Senescence and Cancer provides insight into established practices and research into apoptosis and senescence by thoroughly examining novel and emerging techniques and research in the fields of cell death pathways, senescence growth arrest, drugs and resistance, DNA damage response, and other topics which still hold mysteries for researchers.

The volume is divided into six easy to follow sections. The first is Apoptosis and Alternative Modes of Cell Death, followed by chapters on Telomeres and Telomerase, Senescence, Genomic Instability and Tumorigenesis. The third part covers DNA Damage Response, Signaling Pathways and Tumorigenesis, while the fourth delves into Resistance and Sensitization. The book concludes with Established Cancer Therapies and a section which looks toward the future with Recent and Developing Cancer Therapies.

In total, this volume provides basic scientists and clinicians with a deeper and more complete understanding of the cellular responses of malignancies which may determine the effectiveness of treatment, both in the initial stages of the disease as well as in disease recurrence.

Title:Apoptosis, Senescence and CancerFormat:PaperbackDimensions:599 pages, 25.4 × 17.8 × 0.01 inPublished:December 9, 2010Publisher:Springer NatureLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:1617376213

ISBN - 13:9781617376214

Look for similar items by category:


Table of Contents

Apoptosis, Senescence and Cancer Section I: Apoptosis and Alternative Models of Cell Death Chapter 1. The intrinsic pathway of apoptosis. Scott H. Kaufman Chapter 2. The extrinsic pathway of apoptosis. M. Stacey Ricci and Wafik S. El-Deiry Chapter 3. Evaluating the importance of apoptosis and other determinants of cell death and survival. Bradley G. Wouters and Roland K. Chiu Chapter 4. Mitotic catastrophe. Fiorenza Ianzini and Michael A. Mackey Chapter 5. Autophagy and autophagic cell death. Mojgan Djavaheri-Mergny, Joelle Botti and Patrice Codogno Chapter 6. Regulation and function of detachment-induced cell death (anoikis) in cancer progression and metastasis. David J. McConkey and Victor Bondar Section II. Telomeres and Telomerase, Senescence, Genomic Instability and Tumorigenesis Chapter 7. Structure and function of the telomere. Jay E. Johnson and Dominique Broccoli Chapter 8. Overview of Senescence. Ruben D. Ramirez Chapter 9. Contributions of telomerase to tumorigenesis. Richard Possemato and William C. Hahn Chapter 10. The role of telomeres in genomic instability. John P. Murnane Section III. DNA Damage Response, Signaling Pathways and Tumorigenesis Chapter 11. Overview of the DNA damage checkpoint -- ATM and ATR. Aude Dupre and Jean Gautier Chapter 12. Interactions between myc and cyclin dependent kinase inhibitors in cancer. Kirsteen H. Maclean and John L. Cleveland Chapter 13. Interplay between H2AX and 53BP1 pathways in DNA double strand break repair response. Fatouros Chronis and Emmy P. Rogakou Chapter 14. DNA-dependent protein kinase in repair, apoptosis, telomere maintenance and chemotherapy. Lawrence F. Povirk Section IV. Resistance and Sensitization Chapter 15. Resistance/signaling pathways. Paul Dent Chapter 16. Ceramide and multi-drug resistance. Myles C. Cabot Chapter 17. Chemo and radio-sensitization through inhibition of PI3/Akt signaling. Debra L. Smith, Laura K. Nolden, Gordon B. Mills and Yiling Lu Chapter 18. The advancement of epidermal growth factor receptor inhibitors in cancer therapy. Gregory W. Allen and Paul M. Harari Section V. Established Cancer Therapies Chapter 19. Antimetabolites. Janet A. Houghton Chapter 20. Topoiseomerase I poisons and apoptotic topoisomerase I-DNA complexes. Olivier Sordet, Yves Pommier and Eric Solary Chapter 21. Perturbations of cellular functions by topoisomerase II inhibitors: all roads lead to cell death? Annette K. Larsen and Andrzej Skladanowski Chapter 22. The significance of poly-targeting in apoptosis induction by alkylating agents and platinum drugs. Jan M. Woynarowski and Barbara A. Woynarowska Chapter 23. Contributions of apoptosis and senescence to cytotoxicity produced by microtubule stabilizing agents. Laura E. Klein and Susan B. Horwitz Section VI. Recent and Developing Cancer Therapies Chapter 24. Tyrosine kinase inhibitors. Michael Deininger Chapter 25. Humanized antibodies. Morton Coleman and Richard Furman Chapter 26. Role of apoptosis in anti-angiogenic cancer therapies. Jennifer A. Doll, Jennifer E. Hobbs and Gerald A. Soff Chapter 27. Photodynamic therapy-induced apoptosis. Nancy L. Oleinick, Rachel L. Morris and Anna Lisa Nieminen Chapter 28. Modulation of TRAIL signaling for cancer therapy. Simone Fulda and Klaus-Michael Debatin

Editorial Reviews

From the reviews of the second edition:"The book provides a comprehensive view in the field of apoptosis, senescence, and cancer therapies. I recommend this book to PhD students in clinical and experimental oncology, pharmacology as well as to lecturers in biological disciplines." (J. Sedlák, Neoplasma, September, 2008)"This book aims to explain basic biological processes and signalling pathways and to link that knowledge to the anticancer drugs associated with those pathways. . The book is generally well written and extremely informative. The information within is as up to date . . I have certainly learnt a lot from reading this book. . recommending it to a laboratory/clinical group or library for purchase." (A Young, British Journal of Cancer, Vol. 100 (5), 2009)"The purpose of the book is to contribute to an understanding of the growth arrest and cell death pathways mediating the response to chemotherapy in tumour cells. . provides basic scientists and clinicians with a deeper and more thorough understanding of the cellular responses of malignant cells to common therapeutic modalities, which may determine the effectiveness of the anti-cancer treatment. This work is an interesting overview of the topics described above and it is well written by experts in the field." (Sylvie Rottey, Acta Clinica Belgica, Vol. 65 (2), 2010)